Penumbra, Inc Operating Lease, Payments
Penumbra, Inc (PEN) reported Operating Lease, Payments of $11.84 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-07-30
- Penumbra, Inc operating lease, payments for the quarter ending 2026-06-30 was $5.94M, a 6.65% increase year-over-year.
- Penumbra, Inc operating lease, payments for the quarter ending 2026-03-31 was $5.91M, a 6.16% increase year-over-year.
- Penumbra, Inc operating lease, payments for the quarter ending 2025-12-31 was $5.88M, a 11.51% increase year-over-year.
- Penumbra, Inc operating lease, payments for the quarter ending 2025-09-30 was $5.57M, a 2.80% increase year-over-year.
- Penumbra, Inc operating lease, payments for fiscal 2025 was $22.58M, a 4.04% increase from fiscal 2024.
- Penumbra, Inc operating lease, payments for fiscal 2024 was $21.71M, a 10.40% increase from fiscal 2023.
- Penumbra, Inc operating lease, payments for fiscal 2023 was $19.66M, a 12.01% increase from fiscal 2022.
- Penumbra, Inc operating lease, payments for fiscal 2022 was $17.55M, a 81.16% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $11.84M 10-Q · filed 2026-07-30 | $17.73M derived: sum of 3 quarters · filed 2026-07-30 | $23.30M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $5.91M 10-Q · filed 2026-05-06 | $11.79M derived: sum of 2 quarters · filed 2026-05-06 | $17.36M derived: sum of 3 quarters · filed 2026-05-06 | $22.93M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $5.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $11.45M derived: sum of 2 quarters · filed 2026-02-25 | $17.02M derived: sum of 3 quarters · filed 2026-07-30 | $22.58M 10-K · filed 2026-02-25 |
| 2025-09-30 | $5.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $11.14M derived: sum of 2 quarters · filed 2026-07-30 | $16.70M 10-Q · filed 2025-11-05 | $21.98M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $5.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $11.13M 10-Q · filed 2026-07-30 | $16.41M derived: sum of 3 quarters · filed 2026-07-30 | $21.82M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $5.56M 10-Q · filed 2026-05-06 | $10.84M derived: sum of 2 quarters · filed 2026-05-06 | $16.26M derived: sum of 3 quarters · filed 2026-05-06 | $21.93M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $5.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $10.69M derived: sum of 2 quarters · filed 2026-02-25 | $16.37M derived: sum of 3 quarters · filed 2026-02-25 | $21.71M 10-K · filed 2026-02-25 |
| 2024-09-30 | $5.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $11.10M derived: sum of 2 quarters · filed 2025-11-05 | $16.43M 10-Q · filed 2025-11-05 | $21.11M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $5.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $11.01M 10-Q · filed 2025-07-29 | $15.69M derived: sum of 3 quarters · filed 2026-02-25 | $20.86M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $5.34M 10-Q · filed 2025-04-23 | $10.01M derived: sum of 2 quarters · filed 2026-02-25 | $15.18M derived: sum of 3 quarters · filed 2026-02-25 | $20.29M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $4.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $9.85M derived: sum of 2 quarters · filed 2026-02-25 | $14.96M derived: sum of 3 quarters · filed 2026-02-25 | $19.66M 10-K · filed 2026-02-25 |
| 2023-09-30 | $5.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $10.28M derived: sum of 2 quarters · filed 2024-10-30 | $14.98M 10-Q · filed 2024-10-30 | $19.52M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $5.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $9.82M 10-Q · filed 2024-07-30 | $14.35M derived: sum of 3 quarters · filed 2025-02-18 | $18.91M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $4.71M 10-Q · filed 2024-05-07 | $9.24M derived: sum of 2 quarters · filed 2025-02-18 | $13.80M derived: sum of 3 quarters · filed 2025-02-18 | $17.99M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $4.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $9.10M derived: sum of 2 quarters · filed 2025-02-18 | $13.29M derived: sum of 3 quarters · filed 2025-02-18 | $17.55M 10-K · filed 2025-02-18 |
| 2022-09-30 | $4.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $8.75M derived: sum of 2 quarters · filed 2023-11-02 | $13.02M 10-Q · filed 2023-11-02 | $16.49M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $4.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $8.46M 10-Q · filed 2023-08-01 | $11.93M derived: sum of 3 quarters · filed 2024-02-22 | $14.23M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $4.27M 10-Q · filed 2023-05-02 | $7.74M derived: sum of 2 quarters · filed 2024-02-22 | $10.04M derived: sum of 3 quarters · filed 2024-02-22 | $12.01M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $5.78M derived: sum of 2 quarters · filed 2024-02-22 | $7.74M derived: sum of 3 quarters · filed 2024-02-22 | $9.69M 10-K · filed 2024-02-22 |
| 2021-09-30 | $2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $4.27M derived: sum of 2 quarters · filed 2022-11-03 | $6.21M 10-Q · filed 2022-11-03 | $8.13M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $1.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $3.91M 10-Q · filed 2022-08-05 | $5.83M derived: sum of 3 quarters · filed 2023-02-23 | $7.74M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $1.95M 10-Q · filed 2022-05-03 | $3.86M derived: sum of 2 quarters · filed 2023-02-23 | $5.77M derived: sum of 3 quarters · filed 2023-02-23 | $7.67M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $3.82M derived: sum of 2 quarters · filed 2023-02-23 | $5.72M derived: sum of 3 quarters · filed 2023-02-23 | $7.56M 10-K · filed 2023-02-23 |
| 2020-09-30 | $1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $3.81M derived: sum of 2 quarters · filed 2021-11-03 | $5.65M 10-Q · filed 2021-11-03 | $7.42M derived: sum of 4 quarters · filed 2021-11-03 |
| 2020-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $3.74M 10-Q · filed 2021-08-09 | $5.51M derived: sum of 3 quarters · filed 2021-08-09 | $7.21M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $1.84M 10-Q · filed 2020-05-07 | $3.61M derived: sum of 2 quarters · filed 2021-02-23 | $5.32M derived: sum of 3 quarters · filed 2021-02-23 | $7.05M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $3.48M derived: sum of 2 quarters · filed 2021-02-23 | $5.21M derived: sum of 3 quarters · filed 2021-02-23 | $6.83M 10-K · filed 2021-02-23 |
| 2019-09-30 | $1.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $3.44M derived: sum of 2 quarters · filed 2020-11-02 | $5.06M 10-Q · filed 2020-11-02 | |
| 2019-06-30 | $1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $3.35M 10-Q · filed 2020-08-03 | ||
| 2019-03-31 | $1.62M 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |